Cigna Investments’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Cigna Investments’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,629	Closed	-$331K	–	923
2017 Q4	$331K	Sell	7,629 -45	-0.6%	-$2.02K	0.02%	656
2017 Q3	$357K	Sell	7,674 -272	-3%	-$13K	0.02%	606
2017 Q2	$393K	Sell	7,946 -13,422	-63%	-$703K	0.03%	535
2017 Q1	$1.17M	Hold	21,368	–	–	0.08%	234
2016 Q4	$1.19M	Buy	+21,368	New	+$1.03M	0.13%	197

Other funds holding BSTC

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Cigna Investments's BSTC Position: Q1 2018 in Review

Cigna Investments sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2018, closing a stake of 7,629 shares — an estimated $331K sold.

Cigna Investments first reported a position in BSTC in Q4 2016 and held it in 5 quarters. The position peaked at $1.19M in Q4 2016. 78 funds tracked by Wall St. Rank hold BSTC as of Q1 2018.

Cigna Investments reported no remaining BioSpecifics Technologies Corp. position as of Q1 2018 after selling out during the quarter.
Cigna Investments sold 7,629 BioSpecifics Technologies Corp. shares in Q1 2018, an estimated $331K.
Cigna Investments first reported a position in BioSpecifics Technologies Corp. in Q4 2016 and held it in 5 quarters.
Cigna Investments's BioSpecifics Technologies Corp. position peaked at $1.19M in Q4 2016.
78 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2018.

Based on Cigna Investments's 13F filing for Q1 2018, filed 9 May 2018.